Navigation Links
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen

ProductsSH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Company BD Biosciences Pharmingen
Item SH3 Proteins II Sampler Kit
Price 
Description SH3 Proteins II Sampler Kit 10g each
Info BD Biosciences PharmingenBD Biosciences Pharmingen
10975 Torreyana Rd.
San Diego, CA 92121
USA
Customer Service: US: 877-232-8995
Tech Support: 800-TALK-TEC (825--5832)
Fax Number: US: 800-325-9637
Web Site: http://www.bdbiosciences.com/pharmingen/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Enzyme Characterization Service from ARVYS Proteins, Inc.
2. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
3. Conditioned Media Production Services from ARVYS Proteins, Inc.
4. Mammalian Cell Mass Production Services from ARVYS Proteins, Inc.
5. Bacterial Cell Paste Production Services from ARVYS Proteins, Inc.
6. Protein Conjugation Services from ARVYS Proteins, Inc.
7. Uniform 13C, 15N, Labeling of Peptides and Proteins new from rPeptide, LLC
8. Mouse Anti-TATA Binding Proteins (TBP) Monoclonal Antibody, Unconjugated, Clone ITBP20 from Covance Research Products, Inc
9. Immunodetection of Specific Proteins from QualTek Molecular Laboratories
10. Essential Techniques: Gel Electrophoresis: Proteins from Promega
11. Proteins LabFax from Promega
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
... Dinitro-5,5'-dithiodibenzoic acid , DTNB , Ellman's reagent ... , *CAS-No.: 69-78-3 *Storage: ... with a reactive grouping not present in the ... reagent which will react directly with the product ...
96 Well Base Plate...
... Inhibitor is a recombinant protein that has been ... in the preparation of cDNA by reverse transcription, ... protein synthesis. RNA Safe Inhibitor tightly binds RNases ... range of eukaryotic RNases such as RNase A, ...
Biology Products:
(Date:6/17/2015)... June 17, 2015  Crossmatch™, a leading provider ... its U.are.U ® 4500 fingerprint readers have ... Eateries, Inc., a San Jose, CA ... increase security, improve accountability and reduce fraud at ... non-repudiable identity confirmation for employee sign in and ...
(Date:6/15/2015)... DALLAS , June 16, 2015 ... Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), ... Worldwide Forecast to 2020" published by MarketsandMarkets, The Natural ... Billion at a CAGR of 18.4% for the forecast ... Tables and   46 F igures spread   ...
(Date:6/10/2015)... , June 10, 2015 ... "3D Sensor Market by Technology (Ultrasound, TOF, Structured ... (consumer Electronics, Entertainment, Automotive) and by Geography - ... by MarketsandMarkets, the market is expected to reach ... of 25.51% between 2015 and 2020. ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 53D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4
... Researchers at the University of Georgia have developed ... ethanol from pretreated pine -- one of the most ... Their research could help biofuels replace gasoline as a ... from woody biomass such as pine, but it is ...
... Human domestication of soybeans is thought to have first occurred ... suggest that cultures in even earlier times and in other ... charred soybean samples from 22 sites in northern China, Japan ... flooring and dumping pits -- with 180 modern charred and ...
... people who initially survive a heart attack, a significant cause ... -- literally, bursting of the heart wall. A ... protein as the key player in the biochemical cascade that ... an Advance Online Publication (AOP) of the journal Nature ...
Cached Biology News:UGA researchers develop 'super' yeast that turns pine into ethanol 2Soybean adoption came early by many cultures, archaeologists say 2Study explains how heart attack can lead to heart rupture 2Study explains how heart attack can lead to heart rupture 3
(Date:7/6/2015)... Calif. , July 6, 2015  Approximately 1% ... is integrated into their chromosomes. These individuals are three ... new study published in one of the nation,s leading ... of Medicine in Canada.  Photo - ... human herpesvirus 6 (HHV-6) causes roseola (also known as ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... cheaper molecular diagnostic tests are key drivers of the global molecular diagnostics market. ... medicine and the introduction of new companion diagnostic tests will increase demand for ...
(Date:7/6/2015)... , July 6, 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: ... Patricia Scheller , Viveve,s Chief Executive Officer, and ... at VirtualInvestorConferences.com on July 9, 2015. , , ... , , , , TIME:     , , ... , , , http://tinyurl.com/viveve   , ...
(Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
Breaking Biology Technology:Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2